Acute Effect of Topical Menthol on Carpal Tunnel Syndrome (IRMA)
This study is not yet open for participant recruitment.
Verified December 2012 by National Research Centre for the Working Environment, Denmark
Sponsor:
National Research Centre for the Working Environment, Denmark
Collaborator:
Marquette University
Information provided by (Responsible Party):
Lars L. Andersen, National Research Centre for the Working Environment, Denmark
ClinicalTrials.gov Identifier:
NCT01716767
First received: October 23, 2012
Last updated: December 5, 2012
Last verified: December 2012
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | October 23, 2012 | ||||
| Last Updated Date | December 5, 2012 | ||||
| Start Date ICMJE | December 2012 | ||||
| Estimated Primary Completion Date | January 2013 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Change in arm/hand pain intensity (scale 0-10) during work [ Time Frame: change from before to after (average of 1,2 and 3 hours after) application of the gel ] [ Designated as safety issue: No ] the participant rates "pain intensity during the last hour" on a scale from 0-10 immediately before, and 1,2,3 hours after application of the gel. The primary outcome is the change from before to after (average of 1,2 and 3 hours after) application of the gel |
||||
| Original Primary Outcome Measures ICMJE |
Change in arm/hand pain intensity (scale 0-10) during work [ Time Frame: change from before to 1 hour after application of the gel ] [ Designated as safety issue: No ] the participant rates "pain intensity during the last hour" on a scale from 0-10 immediately before, and 1,2,3 hours after application of the gel. The primary outcome is the change from before to 1 hour after application of the gel |
||||
| Change History | Complete list of historical versions of study NCT01716767 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
GROC [ Time Frame: 3 hours after application of the gel ] [ Designated as safety issue: No ] Global Rating of Change (GROC) on a scale from - 5(much worsening of pain) to 5(much improvement of pain) |
||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Acute Effect of Topical Menthol on Carpal Tunnel Syndrome | ||||
| Official Title ICMJE | Acute Effect of Topical Menthol on Pain Symptoms in Slaughterhouse Workers With Symptoms of Carpal Tunnel Syndrome: Randomized Controlled Trial | ||||
| Brief Summary | Topical menthol gels are classified 'topical analgesics' and are used to relieve pain of the musculoskeletal system. However, double-blind randomized controlled trials are lacking. Here the investigators examine - in a double-blind randomized controlled cross-over trial - the acute effect of topical menthol (Biofreeze) and placebo (gel with a menthol scent) on pain symptoms in slaughterhouse workers with symptoms of Carpal Tunnel Syndrome. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
||||
| Condition ICMJE | Carpal Tunnel Syndrome | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Not yet recruiting | ||||
| Estimated Enrollment ICMJE | 16 | ||||
| Estimated Completion Date | January 2013 | ||||
| Estimated Primary Completion Date | January 2013 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 67 Years | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Denmark | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01716767 | ||||
| Other Study ID Numbers ICMJE | IRMA07 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Lars L. Andersen, National Research Centre for the Working Environment, Denmark | ||||
| Study Sponsor ICMJE | National Research Centre for the Working Environment, Denmark | ||||
| Collaborators ICMJE | Marquette University | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | National Research Centre for the Working Environment, Denmark | ||||
| Verification Date | December 2012 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||